Beam Therapeutics, launched in 2018, is pioneering the use of CRISPR base editing to develop a broad portfolio of advanced genetic medicines.

Biotechnology

Beam

Beam's headquarters in Cambridge, MA, United States

John Evans

Amy Simon

Lisa Smith

Lee Ownbey

Jennifer Mara

Sravan Emany

Giuseppe Ciaramella

Gopi Shanker

Manmohan Singh

Christine Bellon

John Lo

John Maraganore

Kate Walsh

Feng Zhang

J. Keith Joung

Christi Shaw

Chirfi Guindo

Graham Cooper

Mark Fishman

Carole Ho

David R. Liu

The Research and Development team at Beam Therapeutics focuses on advancing the innovative application of CRISPR base editing to create next-generation genetic medicines. This multidisciplinary group, consisting of experts in areas such as genomics, biophysics, and clinical biomarker development, collaborates to design, optimize, and validate therapeutic candidates while ensuring compliance with regulatory standards. Their work is integral to translating cutting-edge research into viable clinical applications, ultimately enhancing patient outcomes in genetic disorders.

Research and Development

The Finance and Accounting team at Beam Therapeutics is responsible for managing the company’s financial health and strategic fiscal planning. They oversee budgeting, financial reporting, compliance, and accounting operations, ensuring efficient use of resources to support the development of innovative genetic medicines. This team plays a critical role in driving financial strategy and providing insights that guide decision-making across the organization.

Finance and Accounting

The Leadership Team at Beam Therapeutics is responsible for driving the strategic vision and operational execution of the company’s mission to advance genetic medicine through CRISPR base editing. This multidisciplinary team, composed of experts in medical, manufacturing, legal, commercial, technological, financial, and human resources domains, collaborates to ensure innovative product development, regulatory compliance, and market readiness while fostering a culture of scientific excellence and ethical responsibility.

Leadership Team

The Manufacturing and Quality Assurance team at Beam Therapeutics is responsible for overseeing the production processes and ensuring the highest quality standards in the development of CRISPR-based genetic medicines. This team collaborates closely to maintain compliance with regulatory requirements, implement robust quality control measures, and optimize manufacturing practices to ensure the efficient and safe delivery of innovative therapies.

Manufacturing and Quality Assurance

The Clinical Operations team at Beam Therapeutics is responsible for overseeing the planning, execution, and management of clinical trials focused on innovative CRISPR base editing therapies. This team ensures regulatory compliance, coordinates cross-functional collaboration, and optimizes trial designs to advance the development of genetic medicines for hematology and oncology applications. Their expertise drives the successful implementation of clinical strategies that bring transformative treatments to patients.

Clinical Operations

The Data and Technology team at Beam Therapeutics is responsible for leveraging data science, engineering, and cutting-edge technology to support the development of CRISPR-based genetic medicines. This team ensures robust data management, supports IT infrastructure, and maintains information security, facilitating innovation and efficiency across the company’s scientific and operational frameworks.

Beam

Org chart

Board & advisors

Teams

Research and Development

Finance and Accounting

Leadership Team

Manufacturing and Quality Assurance

Clinical Operations

Data and Technology

Offices

Beam

Org chart

Board & advisors

Teams

Research and Development

Finance and Accounting

Leadership Team

Manufacturing and Quality Assurance

Clinical Operations

Data and Technology

Offices

Related companies